[Form 4] Twist Bioscience Corp Insider Trading Activity
Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp (TWST), reported a non-discretionary sale of shares on 09/15/2025 to satisfy tax withholding tied to vested restricted stock units. The reported transaction lists a price of $25.328 per share and shows 102,943 shares beneficially owned by the reporting person after the transaction. The filing was signed by an attorney-in-fact on 09/17/2025. The form states the sale was a mandated "sell to cover" required by the issuer's equity incentive plan and not a discretionary trade by the reporting person.
Dennis Cho, Senior Vice President, Direttore Legale e Segretario Corporativo di Twist Bioscience Corp (TWST), ha comunicato una vendita non discrezionale di azioni il 15/09/2025 per soddisfare la ritenuta d'acconto legata a unità azionarie vincolate maturate (RSU). La transazione riportata indica un prezzo di $25.328 per azione e mostra che il soggetto riportante detiene ora 102,943 azioni. La dichiarazione è stata firmata da un procuratore in forza il 17/09/2025. Il modulo indica che la vendita era un'operazione obbligata di "sell to cover" prevista dal piano di incentivo azionario dell'emittente e non un'operazione discrezionale da parte del soggetto riportante.
Dennis Cho, Vicepresidente Senior, Director Jurídico y Secretario Corporativo de Twist Bioscience Corp (TWST), notificó una venta no discrecional de acciones el 15/09/2025 para cubrir la retención de impuestos vinculada a unidades de acciones restringidas recibidas (RSU). La transacción reportada indica un precio de $25.328 por acción y muestra que, tras la operación, el titular reportante posee 102,943 acciones. La declaración fue firmada por un mandatario en 17/09/2025. El formulario indica que la venta fue un mandato de “sell to cover” exigido por el plan de incentivos de acciones del emisor y no una operación discrecional por parte del informante.
Dennis Cho, Twist Bioscience Corp(TWST)의 부사장 겸 최고법률책임자 및 기업비서가 2025년 9월 15일에 vest된 제한 주식 단위와 관련된 세금 원천징수를 충당하기 위한 비재량적 주식 매도를 보고했습니다. 보고된 거래는 주당 $25.328의 가격을 표시하고 거래 후 보고자가 소유한 주식 수가 102,943주임을 보여줍니다. 이 신고서는 2025년 9월 17일에 대리인이 서명했습니다. 양식은 매도가 발행사의 주식 인센티브 계획에 의해 요구된 의무적 “Sell to Cover”이며 보고자가 재량권으로 한 거래가 아님을 명시합니다.
Dennis Cho, vice-président principal, directeur juridique et secrétaire général de Twist Bioscience Corp (TWST), a signalé une vente non discrétionnaire d’actions le 15/09/2025 afin de satisfaire la retenue fiscale liée aux unités d’actions restreintes acquises. La transaction indiquée affiche un prix de 25,328 $ par action et montre que l’ayant-droit après la transaction détient 102 943 actions. Le formulaire a été signé par un mandataire le 17/09/2025. Le formulaire précise que la vente était une opération « sell to cover » obligée par le plan d’incitation en actions de l’émetteur et non une transaction discrétionnaire de la part du déclarant.
Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary der Twist Bioscience Corp (TWST), meldete am 15.09.2025 einen nicht-discretionären Aktienverkauf, um die steuerlichen Abzüge im Zusammenhang mit vesteten Restricted Stock Units zu erfüllen. Die gemeldete Transaktion weist einen Preis von 25,328 USD pro Aktie aus und zeigt, dass der meldende Inhaber nach der Transaktion 102.943 Aktien besitzt. Die Einreichung wurde von einem Bevollmächtigten am 17.09.2025 unterzeichnet. Das Formular besagt, dass der Verkauf eine vorgeschriebene „Sell to Cover“-Maßnahme gemäß dem Aktienanreizplan des Emittenten war und kein diskretionärer Handel der meldenden Person.
دينيس تشو، نائب الرئيس الأول، المدير القانوني وكاتب سر الشركة في Twist Bioscience Corp (TWST)، أبلغ عن بيع غير اختياري للأسهم في 15/09/2025 لتلبية الحجز الضريبي المرتبط بوحدات الأسهم المقيدة المتحققة. تُظهر المعاملة المبلّغ عنها سعر $25.328 للسهم وتبين أن عدد الأسهم المملوكة لصاحب الإبلاغ بعد المعاملة هو 102,943. تم توقيع الملف من قبل وكيل مفوض في 17/09/2025. النص يشير إلى أن البيع كان إجراءاً إلزامياً من نوع "Sell to Cover" بموجب خطة حوافز الأسهم للمصدر وليس صفقة تقديرية من قبل الشخص المبلغ.
Dennis Cho，Twist Bioscience Corp（TWST）的高级副总裁、首席法务官兼公司秘书，报告于 2025-09-15 进行的非裁量性股票出售，以满足与已归属受限股票单位相关的税款代扣。该交易显示每股价格为 $25.328，交易后报告人所持有的股数为 102,943 股。该备案由一名授权代理人在 2025-09-17 签署。表格指出，此次出售是发行人股权激励计划所要求的“sell to cover”强制性操作，而非报告人进行的自由裁量交易。
- Transaction explicitly identified as non-discretionary sell-to-cover tied to RSU vesting, clarifying the nature of the sale
- Post-transaction beneficial ownership disclosed as 102,943 shares, maintaining transparency on insider holdings
- Insider disposition reported (sell-to-cover), which reduces insider-held shares even if non-discretionary
Insights
TL;DR Routine, non-discretionary sell-to-cover of RSUs by a senior officer; no indication of voluntary cashing out.
The Form 4 documents a mandated sale to satisfy tax withholding on vested restricted stock units for a named officer. Because the filing explicitly states the transaction was a sell-to-cover required under the issuer's equity plan, this is a common administrative event that does not necessarily signal a change in the officer's view of the company. The post-transaction beneficial ownership of 102,943 shares remains disclosed, preserving transparency on insider holdings. No additional governance or related-party issues are disclosed in the filing.
TL;DR Insider sold shares at $25.328 as a tax-withholding action; transaction appears administrative and not material to valuation.
The filing records a sale occurring on 09/15/2025 at a reported price of $25.328 per share described as a sell-to-cover tied to RSU vesting. Such transactions typically reduce an insider's gross share count without indicating portfolio reallocation or liquidity-driven selling. The remaining direct beneficial ownership is reported as 102,943 shares, which continues to provide the market with a snapshot of insider exposure. No derivative transactions or other compensatory arrangements are reported beyond the described withholding sale.
Dennis Cho, Senior Vice President, Direttore Legale e Segretario Corporativo di Twist Bioscience Corp (TWST), ha comunicato una vendita non discrezionale di azioni il 15/09/2025 per soddisfare la ritenuta d'acconto legata a unità azionarie vincolate maturate (RSU). La transazione riportata indica un prezzo di $25.328 per azione e mostra che il soggetto riportante detiene ora 102,943 azioni. La dichiarazione è stata firmata da un procuratore in forza il 17/09/2025. Il modulo indica che la vendita era un'operazione obbligata di "sell to cover" prevista dal piano di incentivo azionario dell'emittente e non un'operazione discrezionale da parte del soggetto riportante.
Dennis Cho, Vicepresidente Senior, Director Jurídico y Secretario Corporativo de Twist Bioscience Corp (TWST), notificó una venta no discrecional de acciones el 15/09/2025 para cubrir la retención de impuestos vinculada a unidades de acciones restringidas recibidas (RSU). La transacción reportada indica un precio de $25.328 por acción y muestra que, tras la operación, el titular reportante posee 102,943 acciones. La declaración fue firmada por un mandatario en 17/09/2025. El formulario indica que la venta fue un mandato de “sell to cover” exigido por el plan de incentivos de acciones del emisor y no una operación discrecional por parte del informante.
Dennis Cho, Twist Bioscience Corp(TWST)의 부사장 겸 최고법률책임자 및 기업비서가 2025년 9월 15일에 vest된 제한 주식 단위와 관련된 세금 원천징수를 충당하기 위한 비재량적 주식 매도를 보고했습니다. 보고된 거래는 주당 $25.328의 가격을 표시하고 거래 후 보고자가 소유한 주식 수가 102,943주임을 보여줍니다. 이 신고서는 2025년 9월 17일에 대리인이 서명했습니다. 양식은 매도가 발행사의 주식 인센티브 계획에 의해 요구된 의무적 “Sell to Cover”이며 보고자가 재량권으로 한 거래가 아님을 명시합니다.
Dennis Cho, vice-président principal, directeur juridique et secrétaire général de Twist Bioscience Corp (TWST), a signalé une vente non discrétionnaire d’actions le 15/09/2025 afin de satisfaire la retenue fiscale liée aux unités d’actions restreintes acquises. La transaction indiquée affiche un prix de 25,328 $ par action et montre que l’ayant-droit après la transaction détient 102 943 actions. Le formulaire a été signé par un mandataire le 17/09/2025. Le formulaire précise que la vente était une opération « sell to cover » obligée par le plan d’incitation en actions de l’émetteur et non une transaction discrétionnaire de la part du déclarant.
Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary der Twist Bioscience Corp (TWST), meldete am 15.09.2025 einen nicht-discretionären Aktienverkauf, um die steuerlichen Abzüge im Zusammenhang mit vesteten Restricted Stock Units zu erfüllen. Die gemeldete Transaktion weist einen Preis von 25,328 USD pro Aktie aus und zeigt, dass der meldende Inhaber nach der Transaktion 102.943 Aktien besitzt. Die Einreichung wurde von einem Bevollmächtigten am 17.09.2025 unterzeichnet. Das Formular besagt, dass der Verkauf eine vorgeschriebene „Sell to Cover“-Maßnahme gemäß dem Aktienanreizplan des Emittenten war und kein diskretionärer Handel der meldenden Person.
FAQ
What did Dennis Cho report on the Form 4 for TWST?
Was the sale by the TWST reporting person discretionary?
What is the reporting person’s title at Twist Bioscience (TWST)?
When was the Form 4 signed and by whom?
How many shares does the reporting person beneficially own after the transaction?
